Intraday Price Movements and Volatility
On 26 Nov 2025, Medico Intercontinental opened the day with an 11.18% gain, touching an intraday high of Rs.37.8. However, the stock experienced considerable volatility throughout the session, with a weighted average price volatility of 12.67%. By the close, the share price had fallen to Rs.29.3, representing a decline of 11.62% on the day and underperforming its sector by 13.37%. This intraday swing highlights the unsettled sentiment surrounding the stock.
Comparison with Market Benchmarks
While Medico Intercontinental faced downward pressure, the broader market showed resilience. The Sensex, after a flat start, climbed 1,106.07 points to close at 85,609.51, a 1.21% rise. The index is trading close to its 52-week high of 85,801.70 and has recorded a 2.88% gain over the past three weeks. Mid-cap stocks led the rally, with the BSE Mid Cap index advancing by 1.32%. In contrast, Medico Intercontinental’s stock has declined by 49.21% over the past year, a stark divergence from the Sensex’s 7.01% gain during the same period.
Technical Indicators and Moving Averages
Technical analysis reveals that Medico Intercontinental is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests sustained downward momentum and a lack of short- to medium-term price support. The 52-week high for the stock stands at Rs.61.75, underscoring the extent of the recent price decline.
Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.
- - New Reliable Performer
- - Steady quarterly gains
- - Fertilizers consistency
Financial Performance Overview
Medico Intercontinental’s financial results over recent quarters have shown subdued activity. The company reported net sales of Rs.20.40 crores in the latest quarter, reflecting a decline of 16.8% compared to the previous four-quarter average. Operating profit before depreciation, interest, and taxes (PBDIT) registered a negative Rs.0.89 crores, marking the lowest level in recent periods. The company’s profit after tax (PAT) for the latest six months stood at a loss of Rs.2.33 crores, with a year-on-year contraction of 25.09%.
Valuation and Return Metrics
Medico Intercontinental’s return on equity (ROE) is currently at zero, indicating an absence of net profitability relative to shareholder equity. The stock trades at a price-to-book value of 0.7, which is considered expensive relative to its peers’ historical valuations. Over the past year, the stock’s total return has been negative 49.21%, while profits have declined by nearly 99.8%. This performance has contributed to the stock’s underperformance against the BSE500 index over one year, three years, and the last three months.
Shareholding and Sector Context
The majority shareholding in Medico Intercontinental remains with the promoters, maintaining a concentrated ownership structure. The company operates within the Trading & Distributors sector, which has experienced mixed performance amid broader market trends. Despite the sector’s overall activity, Medico Intercontinental’s stock has not aligned with the positive momentum seen in mid-cap stocks and the Sensex.
Is Medico Intercontinental your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Recent Trends
Medico Intercontinental’s stock has experienced a notable decline over the past year, with a 52-week low of Rs.29.3 reached today. The stock’s intraday volatility and trading below all major moving averages reflect ongoing market pressures. Financial indicators point to contraction in sales and profitability, with negative returns and valuation metrics that suggest a premium relative to earnings and book value. Meanwhile, the broader market and sector indices have shown strength, highlighting the divergence in performance.
Market Environment and Outlook
The Sensex’s recent upward trajectory, supported by mid-cap leadership and bullish moving averages, contrasts with the subdued performance of Medico Intercontinental. The stock’s current position below key technical levels and its financial results indicate challenges in regaining momentum. Investors and market participants may note the stock’s significant underperformance relative to benchmarks and peers over multiple time frames.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
